Jodi E. Eddy - Aug 2, 2021 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
SVP, Chief Info & Digital Off.
Signature
/s/ Vance R. Brown, Attorney-in-fact
Stock symbol
BSX
Transactions as of
Aug 2, 2021
Transactions value $
-$73,168
Form type
4
Date filed
8/4/2021, 04:36 PM
Previous filing
Jul 27, 2021
Next filing
Sep 1, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Sale -$33.3K -727 -3.5% $45.77 20.1K Aug 2, 2021 Direct F1
transaction BSX Common Stock Options Exercise $0 +1.97K +9.84% $0.00 22K Aug 3, 2021 Direct F2
transaction BSX Common Stock Tax liability -$39.9K -876 -3.98% $45.54 21.1K Aug 3, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Deferred Stock Units Options Exercise $0 -1.97K -24.99% $0.00 5.92K Aug 3, 2021 Common Stock 1.97K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2 Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F3 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on August 3, 2021, the first anniversary of the date of grant.